Challenges in pulmonary fibrosis·2: Bronchiolocentric fibrosis

Thorax

Volumn 62, Issue 7, 2007, Pages 638-649

  Cordier, Jean François ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TOXIC GAS;

ACUTE LUNG INJURY; AIRWAY OBSTRUCTION; ALLOIMMUNITY; BRONCHIOLITIS OBLITERANS; CHEMICAL INJURY; CONNECTIVE TISSUE DISEASE; DYSPNEA; FIBROSING ALVEOLITIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

BRONCHIOLITIS OBLITERANS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUNG TRANSPLANTATION; PULMONARY FIBROSIS;

EID: 34447330710     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2004.031005     Document Type: Review

References (202)

1. Reynaud AC. Mémoire sur l'oblitération des bronches. Mem Acad Med Paris 1835;4:117-67.
2. Lange W. Ueber eine eigenthümliche Erkrankung der kleinen Bronchien und Bronchiolen. (Bronchitis et Bronchiolitis obliterans). Dtsch Arch Klin Med 1901;70:342-64.
3. Fraenkel A. Ueber Bronchiolitis fibrosa obliterans, nebst Bemerkungen über Lungenhyperämie une indurirende Pneumonie. Dtsch Arch Klin Med 1902;73:484-510.
4. Urbanski SJ, Kossakowska AE, Curtis J, et al. Idiopathic small airways pathology in patients with graft-versus-host disease following allogeneic bone marrow transplantation. Am J Surg Pathol 1987;11:965-71.
5. Yousem SA. The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients. Hum Pathol 1995;26:668-75.
6. Myers JL, Colby TV. Bronchiolitis obliterans with organizing pneumonia and constrictive bronchiolitis: comparative analysis of two distinct entities. In: Fenoglio-Preiser CM, Wolff M, Rike F, eds. Progress in surgical pathology. New York: Springer Verlag, 1992:167-79.
7. Yousem SA. Small airways disease. Pathol Annu 1991;26:109-43.
8. Colby TV, Myers JL. Clinical and histologic spectrum of bronchiolitis obliterans including bronchiolitis obliterans organizing pneumonia. Semin Respir Med 1992;13:119-33.
9. Myers JL, Colby TV. Pathologic manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse panbronchiolitis. Clin Chest Med 1993;14:611-22.
10. Colby TV. Bronchiolitis. Pathologic considerations. Am J Clin Pathol 1998;109:101-9.
11. Couture C, Colby TV. Histopathology of bronchiolar disorders. Semin Respir Crit Care Med 2003;24:489-98.
12. Epler GR. The clinician's classification of the diseases of the bronchioles. In: Epler GR, eds. Diseases of the bronchioles. New York: Raven Press, 1994:101-12.
13. American Thoracic Society/European Respiratory Society. Classification of the idiopathic interstitial pneumonias. International multidisciplinary consensus. American Thoracic Society/European Respiratory Society. Am J Respir Crit Care Med 2002;165:277-304.
14. McLean KH. The pathology of acute bronchiolitis: a study of its evolution. Part II: The repair phase. Australas Ann Med 1957;6:29-43.
15. McLean KH. The pathology of acute bronchiolitis: a study of its evolution. Part I: The exudative phase. Australas Ann Med 1956;5:254-67.
16. Wright JL. Inhalational lung injury causing bronchiolitis. Clin Chest Med 1993;14:635-44.
17. Horvath EP, doPico GA, Barbee RA, et al. Nitrogen dioxide-induced pulmonary disease. Five new cases and a review of the literature. J Occup Med 1978;20:103-10.
18. Lowry T, Schuman LM. "Silo-filler's disease": a syndrome caused by nitrogen dioxide. JAMA 1956;162:153-60.
19. McAdams AJ. Bronchiolitis obliterans. Am J Med 1955;19:314-22.
20. Moskowitz RL, Lyons HA, Cottle HR. Silo filler's disease. Clinical, physiologic and pathologic study of a patient. Am J Med 1964;36:457-62.
21. Lenci G, Wacker G, Schulz V, et al. Bronchiolitis obliterans nach Stickstoffdioxyd (NO2)-Inhalation: klinisch- röntgenologisch-histologische Beobachtung. Pneumologie 1990;44:32-6.
22. Arora NS, Aldrich TK. Bronchiolitis obliterans from a burning automobile. South Med J 1980;73:507-10.
23. Moran TJ, Hellstrom HR. Bronchiolitis obliterans. An experimental study of the pathogenesis and the use of cortisone in modification of the lesions. AMA Arch Path J 1958;66:691-707.
24. Cosla CLB, Spilborghs GMGT, Martins MA, et al. Nitric acid-induced bronchiolitis in rats mimics childhood bronchiolitis obliterans. Respiration 2005;72:642-9.
25. Beschorner WE, Saral R, Hutchins GM, et al. Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone marrow transplants. N Engl J Med 1978;299:1030-6.
26. Streichenberger N, Peyrol S, Philit F, et al. Constrictive bronchiolitis obliterans. Characterization of fibrogenesis and lysyl oxidase expression patterns. Virchows Arch 2001;439:78-84.
27. Cordier JF, Peyrol S, Loire R. Bronchiolitis obliterans organizing pneumonia as a model of inflammatory lung disease. In: Epler GR, eds. Diseases of the bronchioles. New York: Raven Press, 1994:313-45.
28. Basset F, Ferrans VJ, Soler P, et al. Intraluminal fibrosis in interstitial lung disorders. Am J Pathol 1986;122:443-61.
29. Peyrol S, Cordier JF, Grimaud JA. Intra-alveolar fibrosis of idiopathic bronchiolitis obliterans-organizing pneumonia. Cell-matrix patterns. Am J Pathol 1990;137:155-70.
30. Dunsmore SE, Shapiro SD. The bone marrow leaves its scar: new concepts in pulmonary fibrosis. J Clin Invest 2004;113:180-2.
31. Hashimoto N, Jin H, Liu T, et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004;113:243-52.
32. Bröcker V, Länger F, Fellous TG, et al. Fibroblasts of recipient origin contribute to bronchiolitis obliterans in human lung transplants. Am J Respir Crit Care Med 2006;173:1276-82.
33. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46.
34. 1/VC ratio does not exclude airway obstruction. Respiration 2004;71:348-52.
35. Stanescu D. Small airways obstruction syndrome. Chest 1999;116:231-3.
36. Evans DJ, Green M. Small airways: a time to revisit? Thorax 1998;53:629-30.
37. Gruber MP, Nana-Sinkam SP, Chan ED. Airflow limitation and dynamic gas trapping in a bone marrow transplant recipient. Respir Care 2004;49:1542-5.
38. Ujita M, Hansell DM. Small-airways diseases: detection and insights with computed tomography. Eur Respir Mon 2004;30:106-44.
39. Hansell DM, Rubens MB, Padley SP, et al. Obliterative bronchiolitis: individual CT signs of small airways disease and functional correlation. Radiology 1997;203:721-6.
40. Stern EJ, Frank MS. Small-airway diseases of the lungs: findings at expiratory CT. AJR 1994;163:37-41.
41. Pipavath SJ, Lynch DA, Cool C, et al. Radiologic and pathologic features of bronchiolitis. AJR 2005;185:354-63.
42. Tanaka N, Matsumoto T, Miura G, et al. Air trapping at CT: high prevalence in asymptomatic subjects with normal pulmonary function. Radiology 2003;227:776-85.
43. Philit F, Wiesendanger T, Archimbaud E, et al. Post-transplant obstructive lung disease ("bronchiolitis obliterans"): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J 1995;8:551-8.
44. Levine SM. Lung transplantation and bronchiolitis obliterans syndrome: are two lungs better than one? Chest 2002;122:1112-4.
45. Hadjiliadis D, Davis RD, Palmer SM. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients? Chest 2002;122:1168-75.
46. Meyers BF, de la Morena M, Sweet SC, et al. Primary graft dysfunction and other selected complications of lung transplantation: a single-center experience of 983 patients. J Thorac Cardiovasc Surg 2005;129:1421-9.
47. Belperio JA, Lake K, Tazelaar H, et al. Bronchiolitis obliterans syndrome complicating lung or heart-lung transplantation. Semin Respir Crit Care Med 2003;24:499-530.
48. Trulock EP, Edwards LB, Taylor DO, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report - 2005. J Heart Lung Transplant 2005;24:956-67.
49. Boucek MM, Edwards LB, Keck BM, et al. Registry of the International Society for Heart and Lung Transplantation: eighth official pediatric report - 2005. J Heart Lung Transplant 2005;24:968-82.
50. Neuringer IP, Chalermskulrat W, Aris R. Obliterative bronchiolitis or chronic lung allograft rejection: a basic science review. J Heart Lung Transplant 2005;24:3-19.
51. Belperio JA, Keane MP, Burdick MD, et al. Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome. J Clin Invest 2005;115:1150-62.
52. Boehler A, Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J 2003;22:1007-18.
53. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002;21:297-310.
54. Sharples LD, McNeil K, Stewart S, et al. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 2002;21:271-81.
55. Tamm M, Aboyoun CL, Chhajed PN, et al. Treated cytomegalovirus pneumonia is not associated with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2004;170:1120-3.
56. Luckraz H, Sharples L, McNeil K, et al. Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation. J Heart Lung Transplant 2003;22:287-91.
57. Khalifah AP, Hachem RR, Chakinala MM, et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004;170:181-7.
58. Cantu III E, Appel JZ, Harlwig MG, et al. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg 2004;78:1142-51.
59. Fiser SM, Tribble CG, Long SM, et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 2002;73:1041-8.
60. Hopkins PM, Aboyoun CL, Chhajed PN, et al. Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis. Am J Respir Crit Care Med 2004;170:1022-6.
61. Roberts DH, Wain JC, Chang Y, et al. Donor-recipient gender mismatch in lung transplantation: impact on obliterative bronchiolitis and survival. J Heart Lung Transplant 2004;23:1252-9.
62. Glanville AR, Gencay M, Tamm M, et al. Chlamydia pneumoniae infection after lung transplantation. J Heart Lung Transplant 2005;24:131-6.
63. Kotsimbos TC, Snell GI, Levvey B, et al. Chlamydia pneumoniae serology in donors and recipients and the risk of bronchiofitis obliterans syndrome after lung transplantation. Transplantation 2005;79:269-75.
64. Fisher AJ, Wardle J, Dark JH, et al. Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS). J Heart Lung Transplant 2002;21:1206- 12.
65. Egan JJ. Obliterative bronchiolitis after lung transplantation: a repetitive multiple injury airway disease. Am J Respir Crit Care Med 2004;170:931-2.
66. Jackson CH, Sharples LD, McNeil K, et al. Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities? J Heart Lung Transplant 2002;21:658-6.
67. Brugiere O, Pessione F, Thabut G, et al. Bronchiolitis obliterans syndrome after single-lung transplantation: impact of time to onset on functional pattern and survival. Chest 2002;121:1883-9.
68. Nathan SD, Barnett SD, Wohlrab J, et al. Bronchiolitis obliterans syndrome: utility of the new guidelines in single lung transplant recipients. J Heart Lung Transplant 2003;22:427-32.
69. Hachem RR, Chakinala MM, Yusen RD, et al. The predictive value of bronchiolitis obliterans syndrome stage 0-p. Am J Respir Crit Care Med 2004;169:468-72.
70. Lama VN, Murray S, Mumford JA, et al. Prognostic value of bronchiolitis obliterans syndrome stage 0-p in single-lung transplant recipients. Am J Respir Crit Care Med 2005;172:379-83.
71. Reynaud-Gaubert M, Thomas P, Badier M, et al. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings. Am J Respir Crit Care Med 2000;161:1924-9.
72. Patterson GM, Wilson S, Whang JL, et al. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. J Heart Lung Transplant 1996;15:175-81.
73. Ouwens JP, van der Mark TW, Koeter GH, et al. Bronchiolar airflow impairment after lung transplantation: an early and common manifestation. J Heart Lung Transplant 2002;21:1056-61.
74. Valentine VG, Taylor DE, Dhillon GS, et al. Success of lung transplantation without surveillance bronchoscopy. J Heart Lung Transplant 2002;21:319-26.
75. Aboyoun CL, Tamm M, Chhajed PN, et al. Diagnostic value of follow-up transbronchial lung biopsy after lung rejection. Am J Respir Crit Care Med 2001;164:460-3.
76. Tamm M, Sharples LD, Higenbottam TW, et al. Bronchiolitis obliterans syndrome in heart-lung transplantation: surveillance biopsies. Am J Respir Crit Care Med 1997;155:1705-10.
77. Yousem SA, Paradis I, Griffith BP. Can transbronchial biopsy aid in the diagnosis of bronchiolitis obliterans in lung transplant recipients? Transplantation 1994;57:151-3.
78. Day JD, Hutchins GM, Hruban RH. Grading pulmonary rejection: a proposal for a simplified system. J Heart Lung Transplant 1994;13:734-7.
79. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996;15:1-15.
80. Chakinala MM, Ritter J, Gage BF, et al. Yield of surveillance bronchoscopy for acute rejection and lymphocytic bronchitis/bronchiolitis after lung transplantation. J Heart Lung Transplant 2004;23:1396-404.
81. Verleden GM, Dupont LJ, Van Raemdonck DE. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Eur Respir J 2005;25:221-4.
82. Cairn J, Yek T, Banner NR, et al. Time-related changes in pulmonary function after conversion to tacrolimus in bronchiolitis obliterans syndrome. J Heart Lung Transplant 2003;22:50-7.
83. Sarahrudi K, Estenne M, Corris P, et al. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection. J Thorac Cardiovasc Surg 2004;127:1126- 32.
84. Yates B, Murphy DM, Forrest IA, et al. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2005;172:772-5.
85. Gerhardt SG, McDyer JF, Girgis RE, et al. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2003;168:121-5.
86. Verleden GM, Dupont LJ. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2004;77:1465-7.
87. Novick RJ, Stitt LW, al-Kattan K, et al. Pulmonary retransplantation: predictors of graft function and survival in 230 patients. Ann Thorac Surg 1998;65:227-34.
88. Kawut SM, Shah L, Wilt JS, et al. Risk factors and outcomes of hypogammaglobulinemia after lung transplantation. Transplantation 2005;79:1723-6.
89. Gilliam AC. Update on graft versus host disease. J Invest Dermatol 2004;123:251-7.
90. Farag SS. Chronic graft-versus-host disease: where do we go from here? Bone Marrow Transplant 2004;33:569-77.
91. Watkins TR, Chien JW, Crawford SW. Graft versus host-associated pulmonary disease and other idiopathic pulmonary complications after hematopoietic stem cell transplant. Semin Respir Crit Care Med 2005;26:482-9.
92. Santo Tomas LH, Loberiza FR, Klein JP, et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest 2005;128:153-61.
93. Ringden O, Remberger M, Ruutu T, et al. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfon versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Blood 1999;93:2196- 201.
94. Chien JW, Martin PJ, Gooley TA, et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003;168:208-14.
95. Dudek AZ, Mahaseth H, DeFor TE, et al. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Tranplant 2003;9:657-66.
96. Holland HK, Wingard JR, Beschorner WE, et al. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-versus-host disease and low serum IgG. Blood 1988;72:621-7.
97. Clark JG, Schwartz DA, Flournoy N, et al. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 1987;107:648-56.
98. Clark JG, Crawford SW, Madtes DK, et al. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989;111:368-76.
99. Nusair S, Breuer R, Shapiro MY, et al. Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation. Eur Respir J 2004;23:440-5.
100. Yoshihara S, Tateishi U, Ando T, et al. Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. Bone Marrow Transplant 2005;35:1195-200.
101. Marras TK, Chan CK. Obliterative bronchiolitis complicating bone marrow transplantation. Semin Respir Crit Care Med 2003;24:531-41.
102. Dall'Amico R, Messina C. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Therapeutic Apheresis 2002;6:296-304.
103. Mauad T, Dolhnikoff M, the Sao Paulo Bronchiolitis Obliterans Study Group. Histology of chilhood bronchiolitis obliterans. Pediatr Pulmonol 2002;33:466-74.
104. Ghanei M, Mokhtari M, Mir Mohammad M, et al. Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography. Eur J Radiol 2004;52:164-9.
105. Thomason JWW, Rice TW, Milstone AP. Bronchiolitis obliterans in a survivor of a chemical weapons attack. JAMA 2003;290:598-9.
106. Konichezky S, Schattner A, Ezri T, et al. Thionyl-chloride-induced lung injury and bronchiolitis obliterans. Chest 1993;104:971-3.
107. Cullinan P, Acquilla S, Dhara VR. Respiratory morbidity 10 years alter the Union Carbide gas leak at Bhopal: a cross sectional survey. The International Medical Commission on Bhopal. BMJ 1997;314:338-42.
108. Zwemer FLJ, Pratt DS, May JJ. Silo filler's disease in New York State. Am Rev Respir Dis 1992;146:650-3.
109. Ramirez J, Dowell AR. Silo filler's disease:nitrogen dioxyde-induced lung injury. Long-term follow-up and review of the literature. Ann Intern Med 1971;74:569-76.
110. Akpinar-Elci M, Travis WD, Lynch DA, et al. Bronchiolitis obliterans syndrome in popcorn production plant workers. Eur Respir J 2004;24:298-302.
111. Kreiss K, Gomaa A, Kullman G, et al. Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N Engl J Med 2002;347:330-8.
112. Churg A, Wright JL, Wiggs B, et al. Small airways disease and mineral dust exposure. Prevalence, structure, and function. Am Rev Respir Dis 1985;131:139-43.
113. Churg A, Wright JL. Small-airway lesions in patients exposed to nonasbestos mineral dusts. Hum Pathol 1983;14:688-93.
114. Wright JL, Cagle P, Churg A, et al. Diseases of the small airways. Am Rev Respir Dis 1992;146:240-62.
115. Honma K, Abraham JL, Chiyotani K, et al. Proposed criteria for mixed-dust pneumoconiosis: definition, descriptions, and guidelines for pathologic diagnosis and clinical correlation. Hum Pathol 2004;35:1515-23.
116. Kobayashi H, Kanoh S, Motoyoshi K, et al. Diffuse lung disease caused by cotton fibre inhalation but distinct from byssinosis. Thorax 2004;59:1095-7.
117. Patel AM, Ryu JH, Reed CE. Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol 2001;108:661-70.
118. Burke GW, Carrington CB, Strauss R, et al. Allergic alveolitis caused by home humidifiers. Unusual clinical features and electron microscopic findings. JAMA 1977;238:2705-8.
119. Reyes CN, Wenzel FJ, Lawton BR, et al. The pulmonary pathology of farmer's lung disease. Chest 1982;81:142-6.
120. Seal RM, Hapke EJ, Thomas GO, et al. The pathology of the acute and chronic stages of farmer's lung. Thorax 1968;23:469-89.
121. Emanuel DA, Wenzel FJ, Bowerman CI, et al. Clinical, pathologic and immunologic study of twenty-four patients. Am J Med 1964;37:392-401.
122. Perez-Padilla R, Gaxiola M, Salas J, et al. Bronchiolitis in chronic pigeon breeder's disease. Morphologic evidence of a spectrum of small airway lesions in hypersensitivity pneumonitis induced by avian antigens. Chest 1996;110:371-7.
123. Churg A, Muller NL, Flint J, et al. Chronic hypersensitivity pneumonitis. Am J Surg Pathol 2006;30:201-8.
124. Patel RA, Sellami D, Gotway MB, et al. Hypersensitivity pneumonitis: patterns on high-resolution CT. J Comput Assist Tomogr 2000;24:965-70.
125. Lynch DA, Newell JD, Logan PM, et al. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? AJR 1995;165:807-11.
126. Adler BD, Padley SP, Muller NL, et al. Chronic hypersensitivity pneumonitis: high-resolution CT and radiographic features in 16 patients. Radiology 1992;185:91-5.
127. Remy-Jardin M, Remy J, Wallaert B, et al. Subacute and chronic bird breeder hypersensitivity pneumonitis: sequential evaluation with CT and correlation with lung function tests and bronchoalveolar lavage. Radiology 1993;189:111-8.
128. Perez-Padilla R, Salas J, Chapela R, et al. Mortality in Mexican patients with chronic pigeon breeder's lung compared with those with usual interstitial pneumonia. Am Rev Respir Dis 1993;148:49-53.
129. Vourlekis JS, Schwarz MI, Cherniack RM, et al. The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis. Am J Med 2004;116:662-8.
130. Fujita J, Ohtsuki Y, Suemitsu I, et al. Pathological and radiological changes in resected lung specimens in Mycobacterium avium intracellulare complex disease. Eur Respir J 1999;13:535-40.
131. Marras TK, Wallace RJ Jr, Koth LL, et al. Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water. Chest 2005;127:664-71.
132. Anon. Case records of the Massachusetts General Hospital. Case 9-2005. N Engl J Med 2005;352:1238-46.
133. Field SK, Fisher D, Cowie RL. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest 2004;126:566-81.
134. Anon. Case records of the Massachusetts General Hospital. Case 27-2000. N Engl J Med 2000;343:642-9.
135. Anon. Case records of the Massachusetts General Hospital. Case 6-1996. N Engl J Med 1996;334:521-6.
136. Hakala M, Paakko P, Sutinen S, et al. Association of bronchiolitis with connective tissue disorders. Ann Rheum Dis 1986;45:656-62.
137. Begin R, Masse S, Cantin A, et al. Airway disease in a subset of nonsmoking rheumatoid patients. Characterization of the disease and evidence for an autoimmune pathogenesis. Am J Med 1982;72:743-50.
138. Geddes DM, Corrin B, Brewerton DA, et al. Progressive airway obliteration in adults and its association with rheumatoid disease. Q J Med 1977;46:427-44.
139. Pegg SJ, Lang BA, Mikhail EL, et al. Fatal bronchiolitis obliterans in a patient with juvenile rheumatoid arthritis receiving chrysotherapy. J Rheumatol 1994;21:549-51.
140. Yam LY, Wong R. Bronchiolitis obliterans and rheumatoid arthritis. Report of a case in a Chinese patient on d-penicillamine and review of the literature. Ann Acad Med Singapore 1993;22:365-8.
141. Penny WJ, Knight RK, Rees AM, et al. Obliterative bronchiolitis in rheumatoid arthritis. Ann Rheum Dis 1982;41:469- 72.
142. Murphy KC, Atkins G, Offer RC, et al. Obliterative bronchiolitis in two rheumatoid arthritis patients treated with penicillamine. Arthritis Rheum 1981;24:557-60.
143. Epler GR, Snider GL, Gaensler EA, et al. Bronchiolitis and bronchitis in connective tissue disease. A possible relationship to the use of penicillamine. JAMA 1979;242:528-32.
144. Jansen HM, Elema JD, Hylkema BS, et al. Progressive obliterative bronchiolitis in a patient with rheumatoid arthritis. Eur J Respir Dis 1982;63(Suppl):43-52.
145. Jacobs P, Bonnyns M, Depierreux M, et al. Rapidly fatal bronchiolitis obliterans with circulating antinuclear and rheumatoid factors. Eur J Respir Dis 1984;65:384-8.
146. Alho HS, Maasilta PK, Harjula AL, et al. Tumor necrosis factor-alpha in a porcine bronchial model of obliterative bronchiolitis. Transplantation 2003;76:516-23.
147. Farivar AS, Mackinnon-Patterson B, McCourtie AS, et al. Obliterative airway disease in rat tracheal allografts requires tumor necrosis factor alpha. Exp Mol Pathol 2005;78:190-7.
148. Cortot AB, Cottin V, Miossec P, et al. Improvement of refractory rheumatoid athritis-associated constrictive bronchiolitis with etanercept. Respir Med 2005;99:511-14.
149. Nousari HC, Deterding R, Wojtczack H, et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med 1999;340:1406-10.
150. Nikolskaia OV, Nousari CH, Anhalt GJ. Paraneoplastic pemphigus in association with Castleman's disease. Br J Dermatol 2003;149:1143- 51.
151. Chin AC, Stich D, White FV, et al. Paraneoplastic pemphigus and bronchiolitis obliterans associated with a mediastinal mass: a rare case of Castleman's disease with respiratory failure requiring lung transplantation. J Pediatr Surg 2001;36:E22.
152. Gudi VS, Ormerod AD, Weir J, et al. Severe breathlessness, mouth ulcers and skin blistering in a female. Eur Respir J 2004;24:884-7.
153. Hoffman MA, Qiao X, Anhalt GJ. CD8+ lymphocytes in bronchiolitis obliterans paraneoplastic pemphigus, and solitary Castleman's disease. N Engl J Med 2003;349:407-8.
154. Hasegawa Y, Shimokata K, Ichiyama S, et al. Constrictive bronchiolitis obliterans and paraneoplastic pemphigus. Eur Respir J 1999;13:934-7.
155. Takahashi M, Shimatsu Y, Kazama T, et al. Paraneoplastic pemphigus associated with bronchiolitis obliterans. Chest 2000;117:603-7.
156. Lai RS, Chiang AA, Wu MT, et al. Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Taiwan. Lancet 1996;348:83-5.
157. Chang YL, Yao YT, Wang NS, et al. Segmental necrosis of small bronchi after prolonged intakes of Sauropus androgynus in Taiwan. Am J Respir Crit Care Med 1998;157:594-8.
158. Wang JS, Tseng HH, Lai RS, et al. Sauropus androgynus-constrictive obliterative bronchitis/bronchiolitis: histopathological study of pneumonectomy and biopsy specimens with emphasis on the inflammatory process and disease progression. Histopathology 2000;37:402-10.
159. Chang H, Wang JS, Tseng HH, et al. Histopathological study of Sauropus androgynus-associated constrictive bronchiolitis obliterans: a new cause of constrictive bronchiolitis obliterans. Am J Surg Pathol 1997;21:35-42.
160. Svetlecic J, Molteni A, Herndon B. Bronchiolitis obliterans induced by intratracheal papaverine: a novel animal model. Lung 2004;182:119-34.
161. Aguayo SM, Miller YE, Waldron JA Jr, et al. Idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med 1992;327:1285-8.
162. Ranchod M. The histogenesis and development of pulmonary tumorlets. Cancer 1977;39:1135-45.
163. Miller RR, Muller NL. Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors. Am J Surg Pathol 1995;19:653-8.
164. Bennett GL, Chew FS. Pulmonary carcinoid tumorlets. AJR 1994;162:568.
165. Brown MJ, English J, Muller NL. Bronchiolitis obliterans due to neuroendocrine hyperplasia: high-resolution CT-pathologic correlation. AJR 1997;168:1561-2.
166. Lee JS, Brown KK, Cool C, et al. Diffuse pulmonary neuroendocrine cell hyperplasia: radiologic and clinical features. J Compur Assist Tomogr 2002;26:180-4.
167. Sheerin N, Harrison NK, Sheppard MN, et al. Obliterative bronchiolitis caused by multiple tumourlets and microcarcinoids successfully treated by single lung transplantation. Thorax 1995;50:207-9.
168. Tazi A, Soler P, Hance AJ. Adult pulmonary Langerhans' cell histiocytosis. Thorax 2000;55:405-16.
169. Kambouchner M, Basset F, Marchal J, et al. Three-dimensional characterization of pathologic lesions in pulmonary Langerhans' cell histiocytosis. Am J Respir Crit Care Med 2002;166:1483-90.
170. Friedman P, Liebow AA, Sokoloff J. Eosinophilic granuloma of lung. Clinical aspects of primary pulmonary histiocytosis in the adult. Medicine (Baltimore) 1981;60:385-96.
171. Cordier JF. Organising pneumonia. Thorax 2000;55:318-28.
172. Travis WD, Hoffman GS, Leavitt RY, et al. Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients. Am J Surg Pathol 1991;15:315-33.
173. Uner AH, Rozum-Slota B, Katzenstein AL. Bronchiolitis obliterans-organizing pneumonia (BOOP)-like variant of Wegener's granulomatosis. A clinicopathologic study of 16 cases. Am J Surg Pathol 1996;20:794-801.
174. Mark EJ, Matsubara O, Tan-Liu NS, et al. The pulmonary biopsy in the early diagnosis of Wegener's (pathergic) granulomatosis: a study based on 35 open lung biopsies. Hum Pathol 1988;19:1065-71.
175. Travis WD, Colby TV, Koss MN, et al. Non-neoplastic disorders of the lower respiratory tract. Washington, DC: American Registry of Pathology and Armed Forces Institute of Pathology, 2002.
176. Hansell DM, Milne DG, Wilsher ML, et al. Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section CT. Radiology 1998;209:697-704.
177. Lavergne F, Clerici C, Sadoun D, et al. Airway obstruction in bronchial sarcoidosis: outcome with treatment. Chest 1999;116:1194-9.
178. Cheung OY, Muhm JR, Helmers RA, et al. Surgical pathology of granulomatous interstitial pneumonia. Ann Diagn Pathol 2003;7:127-38.
179. Culiner MM. Obliterative bronchitis and bronchiolitis with bronchiectasis. Dis Chest 1963;44:351-61.
180. Sobonya RE, Taussig LM. Quantitative aspects of lung pathology in cystic fibrosis. Am Rev Respir Dis 1986;134:290-5.
181. Fraig M, Shreesha U, Savici D, et al. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol 2002;26:647-53.
182. Anon. Case records of the Massachusetts General Hospital. Case 11-1998. N Engl J Med 1998;338:1051-8.
183. Cottin V, Streichenberger N, Gamondes JP, et al. Respiratory bronchiolitis in smokers with spontaneous pneumothorax. Eur Respir J 1998;12:702-4.
184. Chung KF. The role of airway smooth muscle in the pathogenesis of airway wall remodeling in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:347-54.
185. Edwards C, Williams AJ, Asquith P. Bronchopulmonary disease in coeliac patients. J Clin Pathol 1985;38:361-7.
186. Ito M, Nakagawa A, Hirabayashi N, et al. Bronchiolitis obliterans in ataxia-telangiectasia. Virchows Arch 1997;430:131-7.
187. Camus P, Piard F, Ashcroft T, et al. The lung in inflammatory bowel disease. Medicine (Baltimore) 1993;72:151-83.
188. Boehler A, Vogt P, Speich R, et al. Bronchiolitis obliterans in a patient with localized scleroderma treated with D-penicillamine. Eur Respir J 1996;9:1317-9.
189. Schwartzman KJ, Bowie DM, Yeadon C, et al. Constrictive bronchiolitis obliterans following gold therapy for psoriatic arthritis. Eur Respir J 1995;8:2191-3.
190. Fukuoka J, Franks TJ, Colby TV, et al. Peribronchiolar metaplasia: a common histologic lesion in diffuse lung disease and a rare cause of interstitial lung disease: clinicopathologic features of 15 cases. Am J Surg Pathol 2005;29:948-54.
191. Lambert MW. Accessory bronchiole-alveolar communications. J Pathol Bacteriol 1955;70:311-4.
192. Brandt HM, Liebow AA. Acinar type of atypical proliferation in the lung in relation to the canals of Lambert. Am J Pathol 1957;33:582.
193. Chilosi M, Murer B, Doglioni C, et al. Bronchiolar epithelium in idiopathic pulmonary fibrosis/usual interstitial fibrosis. In: Lynch JP, eds. Idiopathic pulmonary fibrosis. New York: Marcel Dekker, 2004:631-64.
194. Yousem SA, Dacic S. Idiopathic bronchiolocentric interstitial pneumonia. Mod Pathol 2002;15:1148-53.
195. Churg A, Wright JL. Bronchiolitis caused by occupational and ambient atmospheric particles. Semin Respir Crit Care Med 2003;24:577-83.
196. Carvalho CR, Bethlem EP. Pulmonary complications of leptospirosis. Clin Chest Med 2002;23:469-78.
197. Thivolet F, Loire R, Cordier JF. Bronchiolitis with peribronchiolar organizing pneumonia (B-POP): a new clinicopathologic entity in bronchiolar/interstitial lung disease? Eur Respir J 1999;14(Suppl 30):272s.
198. Markopoulou KD, Cool CD, Elliott TL, et al. Obliterative bronchiolitis: varying presentations and clinicopathological correlation. Eur Respir J 2002;19:20-30.
199. Kraft M, Mortenson RL, Colby TV, et al. Cryptogenic constrictive bronchiolitis. A clinicopathologic study. Am Rev Respir Dis 1993;148:1093-101.
200. Turton CW, Williams G, Green M. Cryptogenic obliterative bronchiolitis in adults. Thorax 1981;36:805-10.
201. Hawley PC, Whitcomb ME. Bronchiolitis fibrosa obliterans in adults. Arch Intern Med 1981;141:1324-7.
202. Noble MI, Fox B, Horsfield K, et al. Obliterative bronchiolitis with atypical features: CT scan and necropsy findings. Eur Respir J 1993;6:1221-5.